What is Eikon Therapeutics, Inc. 's finance lease liabilities?

Eikon Therapeutics, Inc. (EIKN) reported finance lease liabilities of $0 in Q1 2026.

What does finance lease liabilities mean?

Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.

MYR GroupMYRG

$998K-42.8%

SSR MiningSSRM

$91K-99.9%

Travel + LeisureTNL

$18M-5.3%

Warrior Met CoalHCC

$50.48M+804%

EZP

EzcorpEZPW

$481K-39.7%

Werner EnterprisesWERN

$26.88M—

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's finance lease liabilities?: Eikon Therapeutics, Inc. (EIKN) reported finance lease liabilities of $0 in Q1 2026.
What does finance lease liabilities mean?: Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.